Viral hepatitis A in residents of Novosibirsk: clinical, epidemiological and laboratory characteristics
https://doi.org/10.31549/2542-1174-2025-9-1-76-86
Abstract
I n t r o d u c t i o n . Viral hepatitis A (VHA) remains an urgent problem due to its widespread prevalence in the world, including Russia, high incidence among adults, characteristic epidemic outbreaks, and polymorphism of clinical forms. The world is conventionally divided into countries with high, medium, low, and very low endemicity. Russia is classified as a medium-endemicity country, and there is uneven distribution of cases of the disease across individual territories of the country. In the Novosibirsk region, the incidence of hepatitis A virus (HAV) infection in 2015–2023 was uneven, often explosive, and its rates varied from 28 to 239 cases, which occurred under approximately equal sanitary and epidemiological conditions in the region. The maximum rise in the incidence of HAV infection was recorded in 2017, 2019, and 2023. The incidence rate in 2023 (3,04 per 100 000) exceeded the hepatitis A incidence rate in the Russian Federation by 20,4%. A i m . To evaluate clinical, epidemiological and laboratory parameters in VHA patients hospitalized in the City Infectious Clinical Hospital No. 1 in Novosibirsk from February to April 2024.
M a t e r i a l s a n d m e t h o d s . Clinical, epidemiological and laboratory parameters were analyzed in 56 patients with VHA hospitalized from February to April 2024. The distribution of patients by gender was as follows: 22 men (41,4%), 34 women (58,6%). The median age was 30.3 (15; 62) years. The diagnosis of HAV infection was verified by enzyme immunoassay. To exclude viral hepatitis B and C, hepatitis C total antibodies, hepatitis B antigens and antibodies were determined in the blood serum. Hemogram and blood biochemistry indices were analyzed. Ultrasound examination was used to diagnose pathology of the abdominal cavity organs. When assessing the severity of HAV infection, we followed the criteria of the Clinical Recommendations of the Ministry of Health of the Russian Federation.
R e s u l t s . The dominant age group was represented by individuals aged 15 to 20 years (25%), patients aged 30 to 62 years accounted for 46%, and women predominated. In 19,2% of patients, the contact route of transmission was identified, in 80,8% – the food-borne transmission route. Four outbreaks of VHA were registered. The icteric form of hepatitis A prevailed (87.5%); the severe form was diagnosed in 37% of cases. A relationship between the route of transmission and severity of the disease was found – the severe form was more often observed in food-borne transmission. The clinical picture of VHA was characterized by a typical cyclical course with the presence of influenza-like syndrome, asthenia and dyspeptic syndrome during the pre-icteric phase. In 9% of patients during the pre-icteric phase, abdominal pain was noted, which was a reason for differential diagnosis with surgical pathology. Variability of cytolysis and cholestasis parameters was revealed. In severe cases of VHA, there were manifestations of hepatocellular insufficiency syndrome (hypoalbuminemia down to 24 g/l, a decrease in the prothrombin index down to 33%).
C o n c l u s i o n . Activation of the epidemic process was observed in a season that was not typical for hepatitis A (February – April). The food-borne transmission route was predominant; 46% of patients were over 30 years old. The icteric form prevailed in hospitalized patients (87,5%), and the severe form was observed in 37%. Significant variability in cytolysis and cholestasis syndromes parameters was noted. Hepatocellular insufficiency syndrome was observed in patients with the severe form of hepatitis A.
About the Authors
E. N. UsolkinaRussian Federation
Elena N. Usolkina - Cand. Sci. (Med.), Associate Professor, Department of Infectious Diseases
52, Krasny prosp., Novosibirsk, 630091
E. I. Krasnova
Russian Federation
Elena I. Krasnova – Dr. Sci. (Med.), Professor, Head, Department of Infectious Diseases
Novosibirsk
V. G. Kuznetsova
Russian Federation
Vera G. Kuznetsova - Dr. Sci. (Med.), Professor, Department of Infectious Diseases
Novosibirsk
Y. V. Kazakova
Russian Federation
Yulia V. Kazakova - Cand. Sci. (Med.), Associate Professor, Department of Infectious Diseases
Novosibirsk
V. V. Provorova
Russian Federation
Veronika V. Provorova - Cand. Sci. (Med.), Associate Professor, Department of Infectious Diseases
Novosibirsk
I. V. Krasilnikova
Russian Federation
Irina V. Krasilnikova - Cand. Sci. (Med.), Infectious Disease Specialist
Novosibirsk
M. V. Beznosikova
Russian Federation
Marina V. Beznosikova – Infectious Disease Specialist
Novosibirsk
L. V. Poddubnaya
Russian Federation
Lyudmila V. Poddubnaya – Dr. Sci. (Med.), Professor, Department of Phthisiopulmonology
Novosibirsk
References
1. Bulykin Z.A., Danilovich S.D., Kuryanov A.P., Pozdeeva M.A. Hepatitis A: modern concepts of epidemiology, screening and pathophysiological mechanisms. Universum: Medicine and Pharmacology. 2022;6(89):4- 8. (In Russ.)
2. Mozes K.B., Mozes V.G., Shibelgut M.N. et al. Acute liver failure in pregnant women due to hepatitis A – current understanding of epidemiology, pathogenesis, treatment and prevention. Mother and Baby in Kuzbass. 2019;4(79):11-15. (In Russ.)
3. Burgasova O.A., Volkova V.M., Tetova V.B., Beljaeva N.M. The view of the clinician on features of the clinical course and issues of vaccinal prevention of viral hepatitis A. Medical and Social Expert Evaluation and Rehabilitation, Russian Journal. 2017;20(1):37-45. DOI: 10.18821/1560-9537-2017-20-1-37-45. (In Russ.)
4. Jacobsen K.H. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb. Perspect. Med. 2018;8(10):a031716. DOI: 10.1101/cshperspect.a031716.
5. Patterson J., Abdullahi L., Hussey G.D. et al. A systematic review of the epidemiology of hepatitis A in Africa. BMC Infect. Dis. 2019;19(1):651. DOI: 10.1186/s12879- 019-4235-5.
6. Fyedorova I.V. Clinical and epidemiological profile of hepatitis A under the conditions of low endemicity. Meditsinskie novosti. 2019;9(300):35-38. (In Russ.) 7. Kalinina E.N., Emelyanova A.N., Chuprova G.A., Nakhapetyan N.A. Viral hepatitis A: clinical features in the adult patients. Siberian Medical Journal (Irkutsk). 2017;2:39-41. (In Russ.)
7. On the state of sanitary and epidemiological wellbeing of the population in the Russian Federation in 2023: State report. Moscow: Federal Service for Surveillance on Consumer Rights Protection and Human Welfare, 2024. 368 p. URL: https://rospotrebnadzor.ru/upload/iblock/fbc/sd3prfszlc9c2r4xbmsb7o3us-38nrvpk/Gosudarstvennyy-doklad-_O-sostoyaniisanitarno_epidemiologicheskogo-blagopoluchiya-naseleniya-v-Rossiyskoy-Federatsii-v-2023-godu_..pdf (accessed 26.12.2024).
8. Provotorov V.Ya., Kiseleva V.V., Belokonova L.V. The question of early viral hepatitis A diagnosis. The Bulletin of Contemporary Clinical Medicine. 2018;11(1):49- 52. DOI: 10.20969/VSKM.2018.11(1).49-52. (In Russ.)
9. On the state of sanitary and epidemiological well-being of the population in the Novosibirsk region in 2016– 2022. State reports.
10. On the state of sanitary and epidemiological well-being of the population in the Novosibirsk region in 2023: State report. 289 p. URL: https://54.rospotrebnadzor.ru/sites/default/files/gosudarstvennyy_doklad_o_seb_v_novosibirskoy_oblasti_za_2023_god.pdf (accessed 26.12.2024)
11. Acute Hepatitis A in Adults: Clinical Practice Guidelines (2021) / National Scientific Society of Infectious Disease Specialists. 66 p. URL: https://www.policlinika-fts.ru/upload/medialibrary/644/6446609f9ad190b44fb7c9599e1089fd.pdf (accessed 26.12.2024)
12. Imanbaeva L.A., Buranchieva A.A., Moukhammad S. Features of the course of viral hepatitis A and acute viral hepatitis B in persons infected with the herpes simplex virus. Scientific Review. Medical Sciences. 2022;2:56-61. DOI: 10.17513/srms.1241. (In Russ.)
Review
For citations:
Usolkina E.N., Krasnova E.I., Kuznetsova V.G., Kazakova Y.V., Provorova V.V., Krasilnikova I.V., Beznosikova M.V., Poddubnaya L.V. Viral hepatitis A in residents of Novosibirsk: clinical, epidemiological and laboratory characteristics. Journal of Siberian Medical Sciences. 2025;(1):76-86. (In Russ.) https://doi.org/10.31549/2542-1174-2025-9-1-76-86